Who has invested in Proviva Therapeutics?

OrbiMed, Hankang Capital, HSG, Viva BioInnovator are named among the investors backing Proviva Therapeutics.

Proviva Therapeutics Funding: $13M Raised, Series A (2025)

Proviva Therapeutics funding overview

Proviva Therapeutics is based in Greater Boston. Proviva Therapeutics has raised $13M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Proviva Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include OrbiMed, Hankang Capital, HSG, Viva BioInnovator. 4 distinct backers are named across the disclosed rounds.

Proviva Therapeutics at a glance

Total raised: $13M
Latest round: Series A
Latest round date: December 2025
Headquarters: Greater Boston
Notable investors: OrbiMed, Hankang Capital, HSG, Viva BioInnovator

Frequently asked about Proviva Therapeutics funding

How much has Proviva Therapeutics raised?: Proviva Therapeutics has raised $13M in total disclosed funding across the rounds on record.
Who has invested in Proviva Therapeutics?: OrbiMed, Hankang Capital, HSG, Viva BioInnovator are named among the investors backing Proviva Therapeutics.
What was the latest Proviva Therapeutics funding round?: The most recent disclosed round is a Series A, announced in December 2025.
Where is Proviva Therapeutics based?: Proviva Therapeutics is based in Greater Boston.
When did Proviva Therapeutics last raise?: The last disclosed Proviva Therapeutics round closed in December 2025 at Series A.

We update the Proviva Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Greater Boston and their backers are listed below.

Proviva Therapeutics Funding: $13M Raised, Series A (2025)

Proviva Therapeutics funding overview

Proviva Therapeutics at a glance

Frequently asked about Proviva Therapeutics funding

Companies related to Proviva Therapeutics (23)

Browse related funding lists (4)